.
biotechrabbit GmbH
biotechrabbit is determined to offer the best products and services to those who lead the way in research. The valued relationships with our partners and customers drive us to exceed current limitations with flexibility, innovation and highly customized solutions to match their specific requirements. Each member of our team of highly engaged scientists, experienced managers and talented business developers aims to facilitate our partners and customers to leap and lead progress in the life science. Covering the whole workflow from enzyme production, ReadyMix development and lyophilization, biotechrabbit is the partner of choice for supplying molecular biology enzymes, reagents and mixes to diagnostics and life sciences. Our way of doing business combines the passion and pure curiosity of excellent researchers with the agile spirit of true entrepreneurs. | Covering the whole workflow from enzyme production, ReadyMix development and lyophilization, biotechrabbit is the partner of choice for supplying molecular biology enzymes, reagents and mixes to diagnostics and life sciences. biotechrabbit is determined to offer the best products and services to those who lead the way in research. The valued relationships with our partners and customers drive us to exceed current limitations with flexibility, innovation and highly customized solutions to match their specific requirements. Each member of our team of highly engaged scientists, experienced managers and talented business developers aims to facilitate our partners and customers to leap and lead progress in the life science. Our way of doing business combines the passion and pure curiosity of excellent researchers with the agile spirit of true entrepreneurs.
BIOTECHNOLOGY VALLEY
The Biotechnology Industrialists’ Association (BİYOSAD) aims to drive human development via innovative, high value-added products and services and is establishing the Biotechnology Valley within the Biotechnology Specialized Industrial Zone (BİOSB) in Istanbul. This project aspires to situate Turkey among the world’s leading biotechnology hubs. Biotechnology Valley, positioned in strategically located Tuzla, Istanbul, is a comprehensive initiative designed to create a specialized biotechnology ecosystem. The project aims to boost Turkey’s global presence in the biotechnology market through strong collaborations between business, academia, and the government. It spans 2.7 million square meters and will feature technology development zones, R&D centers, testing and calibration labs, patent offices, and specialized biotechnology schools. Our goal is to enhance global export potential by fostering domestic production of high value-added biotechnology products. We prioritize guiding industry and academia toward innovative collaboration, exploring nature’s possibilities in light of science. Our mission extends beyond meeting current demands to making a positive impact for future generations through sustainable and collaborative efforts. Biotechnology Valley is dedicated to enabling breakthrough technologies in the sector and hosting research that benefits society, adding value to both science and business. We are committed to providing a safe, innovative, and supportive business environment for all sector stakeholders. Join us as a partner in transforming Türkiye and the world into a leading biotechnology center. | Biotechnology Valley is a strategic technology and innovation ecosystem established under the leadership of the Biotechnology Industrialists Association (BIYOSAD) to lead Türkiye’s vision in biotechnology across science, technology, and production. Bringing together the public sector, industry, academia, and investors, the Valley aims to build a high–value-added, sustainable, and globally competitive biotechnology infrastructure. Located in Tepeören, Istanbul, and spanning approximately 2.7 million square meters, Biotechnology Valley is one of Türkiye’s most comprehensive biotechnology initiatives. With its advanced R&D centers, technology development zones, modern manufacturing facilities, and shared infrastructure, the Valley is designed as an integrated hub for local and international companies operating in pharmaceuticals, biotechnology products, medical technologies, and advanced life sciences. Biotechnology Valley is not only a center for production and R&D, but also a living and innovation ecosystem with sustainability at its core. The project prioritizes energy-efficient infrastructure, renewable energy solutions, water efficiency practices, integrated waste management systems, and comprehensive strategies to reduce carbon footprint. This approach positions biotechnology production in harmony with nature and with a strong sense of responsibility toward future generations. The Valley offers a collaborative, innovative, and scalable ecosystem for a wide range of stakeholders, from start-ups and research institutions to global players and investment funds. Through its open innovation approach, Biotechnology Valley promotes knowledge sharing and co-creation, aiming to integrate Türkiye’s biotechnology potential into the global value chain. With its robust infrastructure, sustainability-driven framework, and international vision, Biotechnology Valley continues to advance with determination toward becoming a regional and global center for biotechnology.
BIOSYNTH
Securing Life Sciences Supply Chains – where Chemistry meets Biology, Products meet Services and Innovation meets Quality, Biosynth is at the Edge of Innovation. With an unrivalled research product portfolio of over a million products and end-to-end manufacturing services, we are science led and customer-focused to solve problems, taking pride in delivering products and projects that others cannot. Our expertise and capabilities run across Complex Chemicals, Peptides and Key Biologics all from one trusted partner. Supplying the pharmaceutical, life science and diagnostic sectors, along with customers across food, agrochemistry and cosmetics, we have facilities across three continents and a rapid global distribution network. We produce chemicals on the milligram to ton scale, and at ISO 9001 and GMP, with peptides at mg to multikilogram scale. | Critical Raw Materials and Services for Diagnostics, Vaccines and Pharmaceuticals – where Chemistry meets Biology, Products meet Services and Innovation meets Quality, Biosynth is at the Edge of Innovation. With an unrivalled research product portfolio of over a million products and end-to-end manufacturing services, we are science led and customer-focused to solve problems, taking pride in delivering products and projects that others cannot. Our expertise and capabilities run across Complex Chemicals, Peptides and Key Biologics all from one trusted partner. Supplying the pharmaceutical, life science and diagnostic sectors, along with customers across food, agrochemistry and cosmetics, we have facilities across three continents and a rapid global distribution network. We produce chemicals on the milligram to ton scale, and at ISO 9001 and GMP, with peptides at mg to multikilogram scale. Find out more at www.biosynth.com. | Securing Life Sciences Supply Chains – where Chemistry meets Biology, Products meet Services and Innovation meets Quality, Biosynth is at the Edge of Innovation. With an unrivalled research product portfolio and end-to-end manufacturing services, we are science led and customer focused to solve problems and deliver key reagents at scale and quality. Our expertise and capability runs across Complex Chemicals, Peptides and Key Biologics all from one trusted partner. Biosynth is an innovative life sciences reagents, custom synthesis and manufacturing services company. We are by scientists, for scientists, securing supply chains with consistent quality, across the globe. We manufacture and source a vast range of chemical and biochemical products, and take pride in delivering products that others cannot. We are experts in complex chemistry, peptides and key biological raw materials. We provide a full range of products and services to support life science research and development, with more than half a million products in our research catalog and hundreds of complex manufacturing service projects. Our complex chemistry specialties include enzyme substrates, carbohydrate and nucleoside chemistry, with manufacturing services from the first idea to the finished product, from route scouting to GMP or ton scale production. For peptides, we also have a full end-to-end offering, from lead discovery and optimization, library production, through to GMP NCE or Neoantigen projects. Across biologics we have a synergistic offering, with an extensive range of custom bioprocessing enzyme projects for production of key products. We are also able to offer custom antibody projects, and epitope mapping. Through the Biosynth group we also offer development of antibodies, antigens and supply of plasma for in vitro diagnostics. The trusted supplier, manufacturer and partner for the pharmaceutical, life science and diagnostic sectors, along with customers across food, agrochemistry and cosmetics, we have facilities across three continents and a rapid global distribution network. Our main chemical research and manufacturing laboratories are in Switzerland, the United Kingdom, Slovakia and China, with peptide production in the USA and the Netherlands. Enzyme projects are based in Austria and biological IVD reagents in Ireland. Our R&D resources and production facilities are modern and versatile, allowing us to produce chemicals on the milligram to ton scale, and at ISO 9001 and GMP, with peptides at mg to multikilogram scale.
BioSpyder
BioSpyder Technologies Inc. has developed a novel product for targeted sequencing called TempO-Seq™, a gene expression profiling tool designed to monitor hundreds to thousands of genes at once in high throughput. TempO-Seq can analyze expression in samples with thousands of cells or from single cells without pre-amplification, maximizing utilization of precious or limited samples. Sample barcoding, together with sequencing short fragments of each gene, enables pooling up to 6,144 samples in one sequencing run. Assay content is flexible and customizable delivering unprecedented accuracy and sensitivity with simplified data analysis that eliminates the need for bioinformatics. TempO-Seq assays deliver an easy to use solution for customers doing expression profiling for any species.
Biosima
BioSima, a biotech company founded in 2022 and based in Brazil, has pioneered an innovative platform for developing exosome-based biopharmaceuticals. BioSima’s products are focused on addressing unmet medical needs by conventional therapies applied in Endocrinology (Diabetes), bone reconstruction (Orthopedics and Dentistry), and Neurology (Alzheimer’s disease). BioSima’s biopharmaceuticals are developed utilizing cutting-edge R&D techniques applicable for regenerative medicine, employing exosome concentrates—nanometric extracellular vesicles produced naturally by living cells and concentrated through specific patented methods. Acting as active ingredients of biopharmaceuticals, these exosomes deliver their genetic and protein cargo to target local undifferentiated cells, aiming to stimulate their proliferative and differentiation potential for healing and repairing of diseased living tissues and organs. BioSima has built a solid track record in Brazil’s biotechnology innovation landscape, achieving significant financial milestones that strengthen its scientific and technological development capacity. Since its inception, the company has stood out in highly competitive public funding programs for applied research, securing support through federal initiatives in Brazil such as FINEP and the Ministry of Science, Technology and Innovation (MCTI). A key highlight is its approval under the “INOVADOC-Brazil” FINEP program, which provides non-reimbursable grants to high-impact projects in health and sustainability. In addition to government-backed funding, BioSima has successfully attracted seed capital from private sources — including angel investors with equity-based funding mechanisms tailored to deep tech startups. This financial support has enabled the company to structure a robust program for the development of exosome-based therapeutic products. It has also driven the consolidation of BioSima’s R&D infrastructure, the development of analytical methods, and the execution of preclinical safety and efficacy studies, both in vitro and in vivo. These advancements have positioned BioSima strategically to start regulatory planning and the technical processes required for clinical trial submissions to health authorities such as ANVISA (Brazil), FDA and EMA, in compliance with international good practices in biopharmaceutical development. The company’s financial and operational achievements to date reflect not only its strong technical foundation but also its institutional readiness and business maturity to meet the complex challenges of healthcare innovation.
BIORON GmbH
BIORON GmbH is a trusted manufacturer and global distributor of molecular biology tools and diagnostic solutions with over 20 years of experience. Located in Germany, we specialize in raw materials for PCR applications and human DNA products (like Human Placenta DNA or COT I Human DNA) e. g. for hybridization assays. Certified according to ISO 13485 standards, we ensure that our products meet highest quality and health requirements. Our dedicated Team includes highly motivated and qualified scientists and molecular biology experts. BIORON is committed to provide advanced solutions for life science research and diagnostic production.
Biopôle SA
Biopôle Lausanne is one of the largest life sciences campus in Europe, hosting a vibrant community of world-renowned industry players and research institutes, based in Lausanne, Switzerland (www.biopole.ch). It offers a world-class combination of modern infrastructure (134,000 sqm of office/lab space), added value services, an extensive network, innovation and funding programmes, and unparalleled community engagement where members can thrive and bring science to life. Biopôle houses 130+ life sciences companies, including 50 biotech/pharma such as Ferring, Roche, Ichnos, etc. and world-class research organizations (Lausanne University Hospital (CHUV), University of Lausanne (UNIL), the Ludwig Institute for Cancer Research etc.), a life science incubator (StartLab), ready-to-move-in private labs (Superlab), a Digital Health Hub (DH2) enabling the emergence of outstanding innovation for the betterment of healthcare. Join Biopôle.